Cargando…

Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment

[Image: see text] Tumor immune microenvironment (TIME) regulators are promising cancer immunotherapeutic targets. IGF2BP1, as a crucial N(6)-methyladenosine (m(6)A) reader protein, recognizes m(6)A target transcripts, ultimately leading to cancer development. However, currently, the biological funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Guo, Qiang, Yang, Heng, Zhang, Xiao-Wen, Feng, Na, Wang, Jing-Kang, Liu, Ting-Ting, Zeng, Ke-Wu, Tu, Peng-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413439/ https://www.ncbi.nlm.nih.gov/pubmed/36032766 http://dx.doi.org/10.1021/acscentsci.2c00107

Ejemplares similares

Allosteric Activation of Transglutaminase 2 via Inducing an “Open” Conformation for Osteoblast Differentiation
por: Yang, Zhuo, et al.
Publicado: (2023)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Allosteric Activation of Transglutaminase 2 via Inducing an “Open” Conformation for Osteoblast Differentiation (Adv. Sci. 18/2023)
por: Yang, Zhuo, et al.
Publicado: (2023)

IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
por: Elcheva, Irina A., et al.
Publicado: (2023)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
Publicado: (2023)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA–protein ternary complex
por: Ma, Qiang, et al.
Publicado: (2022)

LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis
por: Yang, Juze, et al.
Publicado: (2022)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

Genetic and Dietary Determinants of Insulin-Like Growth Factor (IGF)-1 and IGF Binding Protein (BP)-3 Levels among Chinese Women
por: Wang, Qiong, et al.
Publicado: (2014)

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis
por: Peng, Wan-Xin, et al.
Publicado: (2022)

Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion
por: Peng, Wenbei, et al.
Publicado: (2023)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

IGF2BP3 May Contributes to Lung Tumorigenesis by Regulating the Alternative Splicing of PKM
por: Xueqing, Huang, et al.
Publicado: (2020)

Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
por: Yu, Xianzhe, et al.
Publicado: (2023)

Mechanism and design of allosteric activators of SIRT1
por: Liu, Fei, et al.
Publicado: (2022)

IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8(+) T Cells in the Tumor Microenvironment
por: Ma, Lingyu, et al.
Publicado: (2023)

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
por: Huang, Wei, et al.
Publicado: (2023)

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
por: Zhang, Meiling, et al.
Publicado: (2021)

RNA‐Binding Protein IGF2BP2/IMP2 is a Critical Maternal Activator in Early Zygotic Genome Activation
por: Liu, Hong‐Bin, et al.
Publicado: (2019)

Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies
por: Ying, Hui, et al.
Publicado: (2023)

Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy
por: Liu, Ting-Ting, et al.
Publicado: (2022)

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression
por: Zhang, Jian, et al.
Publicado: (2020)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications
por: Wan, Yan-Jun, et al.
Publicado: (2020)

m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma
por: Fang, Han, et al.
Publicado: (2023)

Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation
por: Kiselyov, Vladislav V, et al.
Publicado: (2009)

MNSFβ regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness
por: Yang, Qian, et al.
Publicado: (2021)

Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3
por: Wang, Saifeng, et al.
Publicado: (2019)

The immune microenvironment and tissue engineering strategies for spinal cord regeneration
por: Feng, Yuan, et al.
Publicado: (2022)

IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells
por: He, Qing, et al.
Publicado: (2022)

IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding
por: Zhang, Junzhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3hhv405brsd6ogecghggddgm40